IL1B and Alzheimer disease: Additionally, GSPM treatment dose-dependently inhibited the secretion of inflammatory cytokines TNF-α, IL-1β, and IL-6 in the hippocampus of AD mice (Figure 2B), and similarly suppressed their mRNA and protein expression levels (Figures 2C, D).